VolitionRX Ltd. (VNRX)
0.1741
0.00 (0.00%)
USD |
NYAM |
Oct 23, 16:00
0.1754
0.00 (0.00%)
After-Hours: 20:00
VolitionRX Enterprise Value : 9.342M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 9.342M |
| October 22, 2026 | 9.282M |
| October 21, 2026 | 9.249M |
| October 20, 2026 | 9.331M |
| October 19, 2026 | 9.338M |
| October 16, 2026 | 9.414M |
| October 15, 2026 | 9.515M |
| October 14, 2026 | 9.401M |
| October 13, 2026 | 9.470M |
| October 12, 2026 | 9.691M |
| October 09, 2026 | 9.790M |
| October 08, 2026 | 9.887M |
| October 07, 2026 | 9.967M |
| October 06, 2026 | 10.17M |
| October 05, 2026 | 10.04M |
| October 02, 2026 | 10.08M |
| October 01, 2026 | 10.07M |
| September 30, 2026 | 10.35M |
| September 29, 2026 | 10.33M |
| September 28, 2026 | 10.29M |
| September 25, 2026 | 10.36M |
| September 24, 2026 | 10.21M |
| September 23, 2026 | 10.22M |
| September 22, 2026 | 10.42M |
| September 21, 2026 | 10.44M |
| Date | Value |
|---|---|
| September 18, 2026 | 10.38M |
| September 17, 2026 | 10.68M |
| September 16, 2026 | 10.56M |
| September 15, 2026 | 10.73M |
| September 14, 2026 | 11.00M |
| September 11, 2026 | 10.98M |
| September 10, 2026 | 11.34M |
| September 09, 2026 | 11.36M |
| September 08, 2026 | 11.25M |
| September 04, 2026 | 11.46M |
| September 03, 2026 | 11.46M |
| September 02, 2026 | 11.78M |
| September 01, 2026 | 11.99M |
| August 31, 2026 | 12.47M |
| August 28, 2026 | 12.66M |
| August 27, 2026 | 13.28M |
| August 26, 2026 | 11.33M |
| August 25, 2026 | 11.88M |
| August 24, 2026 | 11.95M |
| August 21, 2026 | 12.27M |
| August 20, 2026 | 12.60M |
| August 19, 2026 | 13.12M |
| August 18, 2026 | 12.96M |
| August 17, 2026 | 13.27M |
| August 14, 2026 | 13.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| Align Technology, Inc. | 10.03B |
| AngioDynamics, Inc. | 501.34M |
| Accuray, Inc. | 162.02M |
| Alphatec Holdings, Inc. | 2.205B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.775M |
| Revenue (Quarterly) | 0.3987M |
| Total Expenses (Quarterly) | 8.185M |
| EPS Diluted (Quarterly) | -0.8505 |
| Gross Profit Margin (Quarterly) | 28.37% |
| Profit Margin (Quarterly) | -1.95K% |
| Earnings Yield | -2.21K% |
| Normalized Earnings Yield | -2057.73 |